New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc . (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that it will participate in NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference being held at Florida Atlantic University in Boca Raton, Florida, on Wednesday, December 3, 2025. Jim... Read More

Strong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth NEW PRAGUE, Minn. / Nov 12, 2025 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 (“Q1 FY 2026”). Q1 FY 2026 Company Highlights Net revenues increased... Read More

NEW PRAGUE, Minn. / Oct 29, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will host a conference call the... Read More

Management will present Monday, October 20, 2025 at 10:00 am PT New Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that Company management will participate in the LD Micro Main Event XIX Conference being held October 19-21, 2025 in San Diego. Electromed President and Chief... Read More

NEW PRAGUE, Minn. / Sep 09, 2025 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed to repurchase up to $10.0 million of Electromed common stock. This follows the exhaustion of Electromed’s most recent share repurchase authorization in the fourth quarter of fiscal... Read More

Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth NEW PRAGUE, Minn. / Aug 26, 2025 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2025") and full year ended June 30, 2025 ("FY... Read More

NEW PRAGUE, Minn. / Aug 12, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2025 fourth quarter ended June 30, 2025, on August 26, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00... Read More

Management will present Tuesday, August 12 at 12:30 pm ET NEW PRAGUE, Minn. / Jul 29, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Company management will participate in the Canaccord Genuity 45 th Annual Growth Conference, which will be held August 12-14, 2025 in Boston, MA. Electromed President and... Read More

NEW PRAGUE, MN / ACCESS Newswire / June 9, 2025 / Electromed, Inc. announced that Jim Cunniff, President and Chief Executive Officer, will be presenting at the Investor Summit Virtual taking place on June 10. About Electromed, Inc. Electromed (NYSE American: ELMD) is a profitable and growing medical device company that develops, manufactures, markets and sells innovative High Frequency Chest Wall Oscillation (HFCWO) airway... Read More

NEW PRAGUE, Minn. / May 27, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that the Company will join the small-cap Russell 2000 ® Index and the broad-market Russell 3000 ® Index, effective after the close of U.S. equity markets on June 27, 2025, as part of their 2025 annual reconstitution, according to a... Read More

Strong operational execution results in tenth consecutive quarter of year-over-year revenue and net income growth NEW PRAGUE, Minn. / May 13, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and nine months ended March 31, 2025 (“Q3 FY 2025”). Q3 FY 2025 Company Highlights Net... Read More

NEW PRAGUE, Minn. / Apr 29, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2025 third quarter ended March 31, 2025, on May 13, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00... Read More

New Prague, Minnesota--(Newsfile Corp. - April 3, 2025) - Electromed, Inc. (NYSE American: ELMD) announced today that it will be participating in the 15th Annual LD Micro Invitational at the Westin Grand Central in New York on April 9th and 10th, 2025. Electromed, Inc. is scheduled to present on April 10, 2025 at 02:30 PM. Jim Cunniff, President and Chief Executive Officer, will be representing the company. Interested... Read More

NEW PRAGUE, Minn. / Mar 10, 2025 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on March 6, 2025, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The timing and amount of share repurchases pursuant to the authorization, if any, will be determined by management based on market... Read More

NEW PRAGUE, Minn. / Feb 26, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the following upcoming investor conferences: The Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference Management will present at 10:30 a.m. Eastern Time on Tuesday, March 18,... Read More

Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives NEW PRAGUE, Minn. / Feb 11, 2025 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2024... Read More

NEW PRAGUE, Minn. / Jan 28, 2025 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 second quarter ended December 31, 2024, on February 11, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to... Read More

Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives NEW PRAGUE, Minn. / Nov 12, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 (“Q1 FY 2025”). Q1 FY 2025 Financial... Read More

NEW PRAGUE, Minn. / Oct 29, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 first quarter ended September 30, 2024, on November 12, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to... Read More

Key hire will drive the Company’s market development and therapy adoption initiatives NEW PRAGUE, Minn. / Oct 28, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Peter Horwich as Vice President, Marketing. Mr. Horwich, an accomplished marketing veteran, brings over 20 years of experience in driving... Read More

NEW PRAGUE, Minn. / Sep 11, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The new authorization follows the exhaustion of Electromed’s previous share repurchase authorization in the... Read More

Record Q4 and full year financial results NEW PRAGUE, Minn. / Aug 27, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2024”) and full year (“FY 2024”) ended June 30, 2024. Q4 FY 2024 Financial Highlights Net revenues increased 9.0% to a record $14.8 million in Q4 FY 2024, from... Read More

NEW PRAGUE, Minn. / Aug 14, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 fourth quarter ended June 30, 2024, on August 27, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time... Read More

NEW PRAGUE, Minn. / Aug 07, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity 44th Annual Global Growth Conference being held in Boston on August 13-15, 2024.... Read More

NEW PRAGUE, Minn. / Jun 03, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti June Small-Cap Virtual Conference on June 12-13, 2024. Electromed’s management team will present... Read More

Growth initiatives drive record revenue NEW PRAGUE, Minn. / May 07, 2024 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2024 (“Q3 FY 2024”). Q3 FY 2024 Financial Highlights Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third... Read More

NEW PRAGUE, Minn. / Apr 23, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m.... Read More

NEW PRAGUE, Minn. / Apr 08, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024.... Read More

NEW PRAGUE, Minn. / Feb 28, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024. Electromed’s management team will... Read More

Growth initiatives drive record revenue, improve margins and enhance operational efficiency NEW PRAGUE, Minn. / Feb 13, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2023 (“Q2 FY 2024”). Q2 FY 2024 Financial Highlights Net revenue increased 17% to a... Read More

NEW PRAGUE, Minn. / Jan 29, 2024 / Business Wire / Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB). SmartVest ® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, a clinically proven therapy that... Read More

NEW PRAGUE, Minn. / Jan 24, 2024 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual 2024 Lytham Partners Investor Select Conference on February 1, 2024. Electromed’s management team... Read More

NEW PRAGUE, Minn. / Nov 07, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2023 (“Q1 FY 2024”). Q1 FY 2024 Financial Highlights Net revenue increased 16% to $12.3 million in Q1 FY 2024, from $10.7 million in the first quarter of the prior fiscal year.... Read More

NEW PRAGUE, Minn. / Nov 01, 2023 / Business Wire / Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced its launch of the SmartVest ® Clearway ® Airway Clearance System to the hospital market for inpatient use. The SmartVest Clearway system, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, offers an updated and efficient approach to... Read More

NEW PRAGUE, Minn. / Nov 01, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin... Read More

NEW PRAGUE, Minn. / Oct 24, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 first quarter ended September 30, 2023, on Tuesday, November 7, 2023 after the close of the stock market. Company management will host a conference call the... Read More

Record Annual Revenue Fourth Quarter Revenue Increased 21% Year-Over-Year; Full Year Revenue Increased 15% NEW PRAGUE, Minn. / Aug 22, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2023”) and full year (“FY 2023”) ended June 30, 2023. Q4 FY 2023 Financial... Read More

NEW PRAGUE, Minn. / Aug 08, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 fourth quarter and year ended June 30, 2023, on Tuesday, August 22, 2023 after the close of the stock market. Company management will host a conference call the... Read More

NEW PRAGUE, Minn. / Jul 07, 2023 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it granted equity awards on July 1, 2023 as a material inducement to employment of James L. Cunniff, the newly appointed President and Chief Executive Officer of Electromed. As previously disclosed, Electromed and Mr. Cunniff entered into an... Read More

NEW PRAGUE, Minn. / Jun 06, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual Sidoti Summer Small Cap Conference on June 14-15, 2023. Electromed’s management team will... Read More

Healthcare Executive Brings More Than 30 Years of Executive Experience and Commercial Success to Electromed NEW PRAGUE, Minn. / Jun 05, 2023 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Jim Cunniff as its new President and Chief Executive Officer (CEO), effective July 1, 2023. Mr. Cunniff will also join... Read More

Quarterly Net Revenue Increase of 19% Year-over-Year NEW PRAGUE, Minn. / May 09, 2023 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 (“Q3 FY 2023”). Q3 FY 2023 Highlights Record quarterly net revenues of $12.1 million, a 19% year-over-year increase Homecare revenue of... Read More

NEW PRAGUE, Minn. / Apr 27, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Inaugural EF Hutton Global Conference on May 10-11, 2023 at the Plaza Hotel in New York, New York.... Read More

NEW PRAGUE, Minn. / Apr 25, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 third quarter ended March 31, 2023, on Tuesday, May 9, 2023 after the close of the stock market, and host a conference call at the same day at 5:00 p.m. Eastern... Read More

NEW PRAGUE, Minn. / Feb 14, 2023 / Business Wire / Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 (“Q2 FY 2023”). Q2 FY 2023 Highlights Net revenue was $11.7 million for the three months ended December 31, 2022, a quarterly record and a 15% increase from $10.2 million for the three... Read More

NEW PRAGUE, Minn. / Feb 14, 2023 / Business Wire / Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around July 1, 2023. After her retirement she will serve as a non-employee member and chair of the company’s board of directors. The Board of Directors is... Read More

NEW PRAGUE, Minn. / Jan 31, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 second quarter ended December 31, 2022, on Tuesday, February 14, 2023 after the close of the stock market, and host a conference call the same day at 5:00 p.m.... Read More